Martek to Announce Fourth Quarter 2007 Results on December 12, 2007

COLUMBIA, Md., Nov. 19 Martek BiosciencesCorporation announced that it intends to release the results of its fourthquarter and fiscal year 2007 on December 12, 2007, at approximately 4:00 p.m.Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will hold aconference call to discuss the results of its fourth quarter and fiscal year2007 results with investors. The call is expected to be approximately onehour in duration. The conference call will also be available live via theInternet. All interested parties may listen to the call by visiting Martek'sweb site at http://investors.martek.com.

An archived webcast of the conference call will be available on Martek'swebsite for thirty days. In addition, a recorded playback of the call will beavailable for one week and can be accessed by calling 800-633-8284 andentering pass code 21352515.

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in theinnovation and development of DHA omega-3 products that promote health andwellness through every stage of life. The company produces life'sDHA(TM), asustainable and vegetarian source of the omega-3 fatty acid DHA(docosahexaenoic acid), for use in foods, beverages, infant formula, andsupplements. The company also produces life'sARA(TM) (arachidonic acid), anomega-6 fatty acid, from a sustainable, vegetarian source, for use in infantformula. For more information on Martek Biosciences Corporation, visithttp://www.martek.com.Kyle Stults Investor Relations (410) 740-0081 Cassie France-Kelly Public Relations (410) 740-0081

SOURCE Martek Biosciences Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...